Arcion Therapeutics - Topical Clonidine Gel - Ownership and Business Overview

Life ScienceCompany

Arcion Therapeutics - Topical Clonidine Gel Ownership

Who owns Arcion Therapeutics - Topical Clonidine Gel?

Arcion Therapeutics - Topical Clonidine Gel is owned by BioDelivery Sciences International. It was acquired on March 26, 2013.

Arcion Therapeutics - Topical Clonidine Gel Business Overview

Where is Arcion Therapeutics - Topical Clonidine Gel headquartered?

Arcion Therapeutics - Topical Clonidine Gel is headquartered in United States.

What sector is Arcion Therapeutics - Topical Clonidine Gel in?

Arcion Therapeutics - Topical Clonidine Gel is a life science company.

Life Science M&A Summary in 2013

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2013. The largest life science acquisition in 2013 was Onyx Pharmaceuticals - which was acquired by Amgen for $10.4B.

Join Mergr to view all 191 acquisitions of life science companies in 2013, including 25 acquisitions by private equity firms, and 166 by strategics.

Arcion Therapeutics - Topical Clonidine Gel


United States,

Arcion Therapeutics - Topical Clonidine Gel is used for the treatment of painful diabetic neuropathy (PDN) and potentially other indications. The PDN market is highly under-served by existing products and there is a strong scientific rationale for developing a topical treatment for PDN that delivers analgesia in a way that avoids systemic side effects.


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Arcion Therapeutics - Topical Clonidine Gel

Life Science Companies , United States Companies